vypybiza.wordpress.com
The money was granted in collaboration withthe U.S. Army Medical Researchn and Materiel Command and the throughnthe Ft. Detrick Technology Transfer The purpose of the technologg transfer program is to raiswe awareness of new and developing technologies and fundinh them to transition as viable projectfor follow-on funding in the market place. Each companh that received funding was awardedapproximately $50,000 betweebn March 2008 and May 2009, makinvg up the initiative’s second roundc of financial awards since its $750,0000 program extension. The funds for the program’s secon phase were secured by Sen. Barbara D-Md., and Rep. Roscoe G. R-Md. “The [Ft.
Detrick Technology Transfetr Initiative] program is enabling area businesses to harness the technologies being developex at Fort Detrick and apply them to thecommercial sector,” said “This will lead to new productxs that have the power to create jobs and save Mikulski announced the first phase of the tech transfer program in March 2005 when 11 companies receivedc funding. in Rockville: The companyg is developing a health care technology callexmiTag system, which is a scalable wireless sensor solutiobn for improving patient flow. in Frederick: The companyu is developing a technology called the GeNovw Screento identify, isolate, and producew antibody-like molecules.
in Rockville: The company is developingy an on-demand biotech products includinb a combination vaccine against plagueand anthrax. BioAssay Workx LLC in Ijamsville: The companyy is developing a lateral-flow visual diagnostivc test to detect and differentiater single sample multiplepathogenic poxviruses, includinb variola, vaccinia, and monkeypox. in Catonsville: The company is safety-testing a medical product called ClotFoam, which is a non-compressible, intracavitaruy hemostatic agent.
CynerGene IDMP in Frederick: The companh is developing, validating and implementing a supplemental diagnosisof HIV, and Dengue using its Infectious Diseas e Multiplex Panel approach, which couls allow for creation of LLC in Baltimore: The company is developintg required components and system framework to enables conversational interfaces for telemedicinee tools. Such tools would allo w professional medics touse voice, gesture, and othert human-- computer interactions to access and documentf information in electronic medical records. in Rockville: The company is developing technology to preserve mammalian cells in driee format that can easilybe re-hydrated for a variety of uses.
LLC in The company is evaluating the effect of Imagilin patented probioticsz as a food supplement to enhancre the immune responsiveness of guinea pigs upon immunizatiomn or challenge withvirulent pathogens. The evaluation will suggesf the ability of Imagilin patented probiotics to enhance the immunizatioh ofa vaccine. in The company is developing micropatterned substrates for viralinfectivityu assays. Juxtopia in Baltimore: The companyt is customizing its Wearable Assistance and SituationalAwarenesd (WASA) goggles and service to allow U.S. Army combat medics to access and document information to electricao medical recordsvia hands-free voice-requests and voice-responses.
in The company is developing cell therapiess to treat brain and spinalcord injuries.
No comments:
Post a Comment